Your browser doesn't support javascript.
loading
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Jiao, Xiang; Aravidis, Christos; Marikkannu, Rajeshwari; Rantala, Johanna; Picelli, Simone; Adamovic, Tatjana; Liu, Tao; Maguire, Paula; Kremeyer, Barbara; Luo, Liping; von Holst, Susanna; Kontham, Vinaykumar; Thutkawkorapin, Jessada; Margolin, Sara; Du, Quan; Lundin, Johanna; Michailidou, Kyriaki; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Lush, Michael; Ambrosone, Christine B; Andrulis, Irene L; Anton-Culver, Hoda; Antonenkova, Natalia N; Arndt, Volker; Beckmann, Matthias W; Blomqvist, Carl; Blot, William; Boeckx, Bram; Bojesen, Stig E; Bonanni, Bernardo; Brand, Judith S; Brauch, Hiltrud; Brenner, Hermann; Broeks, Annegien; Brüning, Thomas; Burwinkel, Barbara; Cai, Qiuyin; Chang-Claude, Jenny; Couch, Fergus J; Cox, Angela; Cross, Simon S; Deming-Halverson, Sandra L; Devilee, Peter; Dos-Santos-Silva, Isabel; Dörk, Thilo; Eriksson, Mikael; Fasching, Peter A; Figueroa, Jonine.
Afiliación
  • Jiao X; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Aravidis C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Marikkannu R; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Rantala J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Picelli S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Adamovic T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Liu T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Maguire P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kremeyer B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Luo L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • von Holst S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kontham V; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Thutkawkorapin J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Margolin S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Du Q; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lundin J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Michailidou K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wang Q; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ambrosone CB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Anton-Culver H; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Antonenkova NN; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Arndt V; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Beckmann MW; Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
  • Blomqvist C; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Blot W; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Boeckx B; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Bojesen SE; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Bonanni B; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Brand JS; International Epidemiology Institute, Rockville, MD, USA.
  • Brauch H; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Brenner H; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Broeks A; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brüning T; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Burwinkel B; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Cai Q; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Chang-Claude J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Couch FJ; University of Tübingen, Tübingen, Germany.
  • Cox A; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Deming-Halverson SL; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Devilee P; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Dos-Santos-Silva I; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Dörk T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
  • Eriksson M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Fasching PA; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Figueroa J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Oncotarget ; 8(61): 102769-102782, 2017 Nov 28.
Article en En | MEDLINE | ID: mdl-29262523
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia